(Q46867182)

English

Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit

scientific article published in March 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

author name string

T Saito

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

S Yoshioka

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

Y Iinuma

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

S Takakura

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

N Fujihara

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

T Ichinohe

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

T Ishikawa

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

T Uchiyama

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

S Ichiyama

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

27

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

209-216

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0428-8

21 January 2018

Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0428-8

21 January 2018

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0428-8

21 January 2018

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0428-8

21 January 2018

Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of infection in neutropenic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fever and neutropenia clinical practice guidelines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDC definitions for nosocomial infections, 1988

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of fluoroquinolone prophylaxis to a blood and marrow transplant unit reduces Gram-negative infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18058141

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-007-0428-8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18058141

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46867182&oldid=2208193866"